Market-Moving News for June 18th
Portfolio Pulse from ryanfaloona@benzinga.com
Market-Moving News for June 18th: Intra-Cellular Therapies (ITCI) shares rise 13% after positive Phase 3 trial results for Lumateperone. La-Z-Boy (LZB) shares increase 13% following better-than-expected Q4 earnings. Actelis Networks (ASNS) shares surge 178% after announcing an agreement with Carahsoft to serve as its public sector distributor.
June 18, 2024 | 12:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Actelis Networks shares surge after announcing an agreement with Carahsoft to serve as its public sector distributor.
The new distribution agreement with Carahsoft is a significant development for Actelis Networks, likely to drive substantial investor interest and a sharp increase in stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Intra-Cellular Therapies shares are trading higher after the company announced positive topline results from its second Phase 3 trial evaluating Lumateperone as adjunctive therapy for major depressive disorder.
The positive Phase 3 trial results for Lumateperone meeting primary and key secondary endpoints are likely to boost investor confidence and drive the stock price higher in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
La-Z-Boy shares are trading higher following better-than-expected Q4 earnings.
Better-than-expected Q4 earnings indicate strong financial performance, which is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100